spacer
spacer

PDBsum entry 1ny2

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
1ny2
Contents
Protein chains
36 a.a. *
259 a.a. *
Ligands
ASP-PHE-GLU-GLU-
ILE-PRO-GLU-GLU-
TYS-LEU
ARG-PRO-PRO-GLY
Waters ×51
* Residue conservation analysis

References listed in PDB file
Key reference
Title Mechanisms of arg-Pro-Pro-Gly-Phe inhibition of thrombin.
Authors A.A.Hasan, M.Warnock, M.Nieman, S.Srikanth, F.Mahdi, R.Krishnan, A.Tulinsky, A.H.Schmaier.
Ref. Am J Physiol Heart Circ Physiol, 2003, 285, H183.
PubMed id 12598231
Abstract
Investigations determined the mechanism(s) by which Arg-Pro-Pro-Gly-Phe (RPPGF) inhibits thrombin-induced platelet activation. High concentrations of RPPGF inhibit thrombin-induced coagulant activity. RPPGF binds to the active site of thrombin by forming a parallel beta-strand with Ser214-Gly216 and interacts with His57, Asp189, and Ser195 of the catalytic triad. RPPGF competitively inhibits alpha-thrombin from hydrolyzing Sar-Pro-Arg-paranitroanilide with a Ki = 1.75 +/- 0.03 mM. Other mechanisms were sought to explain why RPPGF inhibits thrombin activation of platelets at concentrations below that which inhibits its active site. Soluble RPPGF blocks biotinylated NATLDPRSFLLR of the thrombin cleavage site on protease-activated receptor (PAR)1 from binding to the peptide RPPGC (IC50 = 20 microM). The soluble recombinant extracellular domain of PAR1 (rPAR1EC) blocks biotinylated RPPGF binding to rPAR1EC (IC50 = 50 microM) bound to microtiter plates, but rPAR1EC deletion mutants missing the sequence LDPR or PRSF do not. RPPGF and related forms prevent the thrombin-like enzyme thrombocytin from proteolyzing rPAR1EC at concentrations that do not block thrombocytin's active site. These studies indicate that RPPGF is a bifunctional inhibitor of thrombin: it binds to PAR1 to prevent thrombin cleavage at Arg41 and interacts with the active site of alpha-thrombin.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer